It is a home appliances private limited company based in Chennai, Tamil Nadu, India, established in 2015.
2015 | Chennai, Tamil Nadu, India | ActiveSmithsante Pharmaceuticals Private Limited, a active private limited company, was established on 05 November 2015 in Chennai, Tamil Nadu, India. Engaging in specialized stores within the home appliances sector, it holds CIN: U52399TN2015PTC102910. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Mathivanan Venugopal (Whole-Time Director), Padinchakara Nirmal Kumar (Whole-Time Director), Venganna Sreenish Kambil (Managing Director). Past directors included Rajiv Tandon, Govindarajan Kumar. It holds ₹1.10 M open charges and ₹0.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at New No.10A, Old No 10A, Left Portion, Ground Floor Gill Nagar 1St Street, Gill Nagar,, Chennai, Tamil Nadu, 600094.
U52399TN2015PTC102910
102910
05 November 2015
₹0.50 M
₹0.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Smithsante Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mathivanan Venugopal | Whole-Time Director | 08 Dec 2023 | Current |
| Padinchakara Nirmal Kumar | Whole-Time Director | 08 Dec 2023 | Current |
| Venganna Sreenish Kambil | Managing Director | 05 Nov 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 23 Feb 2025 | Past |
| Pramod Abcsdd | Director | 18 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Smithsante Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 26.08% decrease. The company also saw a substantial improvement in profitability, with a 98.18% increase in profit. The company's net worth dipped by a decrease of 0.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Smithsante Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,100,000.00
₹500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Mar 2025 | Others | ₹1.10 M | Open |
| 06 Mar 2024 | Others | ₹0.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Smithsante Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Smithsante Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smithsante Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 06 Mar 2024 via Charge ID 100893741 with Others was fully satisfied on 15 Mar 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 1.10 M with Charge ID 101085136 was registered on 10 Mar 2025. was recorded as a recent event.
Smithsante Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Smithsante Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.50 M with Charge ID 100893741 was registered on 06 Mar 2024. was documented.
Progress on Mathivanan Venugopal was appointed as a Whole-time director was appointed as a Whole-time director on 08 Dec 2023 & has been associated with this company since 2 years 10 days . was documented.
The CIN of Smithsante Pharmaceuticals Private Limited is U52399TN2015PTC102910.
Smithsante Pharmaceuticals Private Limited is headquartered at New No.10A, Old No 10A, Left Portion, Ground Floor Gill Nagar 1St Street, Gill Nagar,, Chennai, Tamil Nadu, 600094.
Smithsante Pharmaceuticals Private Limited was incorporated on 05 November 2015.
The current directors of Smithsante Pharmaceuticals Private Limited are
The primary industry of Smithsante Pharmaceuticals Private Limited is Home Appliances.
Smithsante Pharmaceuticals Private Limited is unlisted.
The authorized capital of Smithsante Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Smithsante Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX